Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab). (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ijc.30280

PubMed Identifier: 27450994

Publication URI: http://europepmc.org/abstract/MED/27450994

Type: Journal Article/Review

Volume: 139

Parent Publication: International journal of cancer

Issue: 10

ISSN: 0020-7136